We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£890.00
The 2027-2032 World Outlook for GLP-1 Agonists for Type 2 Diabetes
Price data checked 3 days ago
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£890 today · cheaper than every other day in the last 2 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 59 days · 59 data points
Price Distribution
Price distribution over 59 days • 1 price levels
Price Analysis
Most common price: £890 (59 days, 100.0%)
Price range: £890 - £890
Price levels: 1 different prices over 59 days
Product Specifications
- Format
- paperback
- ASIN
- B0GMQY3FMD
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 05 January 2026
- Listed Since
- 10 February 2026
Similar Products You Might Like
The 2027-2032 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics
The 2027-2032 World Outlook for Glaucoma Pharmaceuticals
The 2027-2032 World Outlook for Interleukin Inhibitors
The 2027-2032 World Outlook for G-Protein Coupled Receptors
The 2027-2032 World Outlook for Lipids
The 2027-2032 World Outlook for Drug Repurposing
The 2027-2032 World Outlook for Antidotes
The 2027-2032 World Outlook for Nutrigenomics
The 2027-2032 World Outlook for Vaccine Adjuvants
The 2027-2032 World Outlook for Endocrine Cell Signaling
The 2027-2032 World Outlook for Hydroxychloroquine Sulphates
The 2027-2032 World Outlook for Xylitol
The 2027-2032 World Outlook for Medium Chain Triglycerides
The 2027-2032 World Outlook for Oligonucleotide Therapeutics for Neurological Disorders
The 2027-2032 World Outlook for Cholestrol Lowering Drugs
The 2027-2032 World Outlook for Lysosomal Storage Diseases
The 2027-2032 World Outlook for Deep Brain Stimulation
The 2027-2032 World Outlook for Opioid Use Disorders
The 2027-2032 World Outlook for Lysosomal Storage Diseases Therapeutics
The 2027-2032 World Outlook for Neuromodulation Deep Brain Stimulation
The 2027-2032 World Outlook for Optic Nerve Disorders Treatments
The 2027-2032 World Outlook for HIV Therapeutics
The 2027-2032 World Outlook for Pharmacy Benefit Management
